29-09-2025, 13:05

Pooled data presented at ERS: nerandomilast monotherapy linked to nominally significant reduction in risk of death in IPF and PPF

Notified -
Globe Newswire29-09-2025, 13:05
10-02-2025, 20:05

Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis

Notified -
Globe Newswire10-02-2025, 20:05